Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

133 participants · First posted Jun 6, 2019

Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of Repeat Topical Application of BOS-356 in Subjects With Moderate to Severe Acne Vulgaris

66 participants · First posted Nov 14, 2019

Imaging and Understanding BOS in Lung Transplantation

6 participants · First posted Dec 12, 2014

BOS-704

BOS-981

BOS-173717

BOS Better Online Solutions

Skin Boss, PLC

United States

BOSTWICK LABORATORIES

United States

Efimosfermin Alfa Shows Promise in Phase 2 MASH Trial

Pimicotinib Shows Promise in Phase 2 Trial for Chronic Graft-versus-Host Disease

Volition's Nu.Q H3.1 Biomarker Shows Promise for Sepsis Assessment in Large ICU Study